SCHEMBL16017262

SCHEMBL16017262

Cc1nc(-c2ccccc2)oc1C(=O)Nc1ccc(-c2cc3c(cc2Cl)OC(F)(F)O3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.48
▸ SMO Q99835 5/20 0.46
▸ DGAT1 O75907 2/20 0.46
▸ KDM4E B2RXH2 3/20 0.44
▸ MAPT P10636 5/20 0.43
▸ POLB P06746 3/20 0.43
▸ USP2 O75604 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ STIM1 Q13586 2/20 0.41
▸ ORAI1 Q96D31 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16017215 0.91 GAA (0.50) GAASMODGAT1KDM4EMAPT
SCHEMBL16018220 0.89 STIM1 (0.49) GAASMODGAT1KDM4EMAPT
SCHEMBL16017234 0.88 HSD17B10 (0.50) MAPTPOLBUSP2HTTHSD17B10
SCHEMBL16018247 0.84 STIM1 (0.61) GAASMODGAT1KDM4EMAPT
SCHEMBL16019776 0.82 ALDH1A1 (0.56) KDM4EMAPTPOLBHSD17B10TSHR
SCHEMBL16017242 0.81 MEN1 (0.54) GAADGAT1KDM4EMAPTPOLB
SCHEMBL14887335 0.80 BACE1 (0.42) GAASMOKDM4EMAPTALDH1A1
SCHEMBL14885684 0.80 STIM1 (0.49) GAADGAT1KDM4EMAPTPOLB
SCHEMBL16017217 0.79 ALDH1A1 (0.57) SMODGAT1MAPTALDH1A1LMNA
SCHEMBL16017213 0.78 GRM1 (0.48) GAAKDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 GAA 994/4885SMO 2189/4885DGAT1 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback